Georgia Bio and Brex Partner to Enhance Member Benefits
Exciting news for Georgia Bio members! The Georgia Bio Brex program, established through our partnership with BIO, has been expanded to provide even greater benefits for your organization. On top of the existing corporate credit card with its industry-specific rewards, members can now access savings on business accounts, spend management software, and travel management solutions.
Upgrade Your Financial Toolkit Learn more and upgrade at bio.org/save/brex
Enhanced Benefits at a Glance
- High-Yield Business Accounts: Enjoy industry-leading yields, effortless wire transfers, and global ACH capabilities with your Brex business account. Brex partner banks offer a competitive 4.92% APY with same-day liquidity, all FDIC-insured up to $6 million. Additionally, you can make free bill payments, international ACH transfers, issue checks, and send wires. Brex accounts can even accommodate up to 240 unique account numbers.
- Scalable Spend Management:
Brex’s advanced spend management system empowers you to manage your company’s spending and close the books in real-time. Features include:
- Budgets with automated enforcement of spending policies
- Streamlined employee reimbursements with advanced approval workflows
- Customizable approval processes to automate in-policy spending approvals
- Global reimbursements in local currencies and accounts
- Automatic receipt generation, eliminating the need for manual receipt collection and expense reports
- Integration with thousands of tools to streamline workflows
- Comprehensive Travel & Expense Management:
Simplify travel and group event management with a unified solution encompassing travel booking, event coordination, expense tracking, corporate cards, and reimbursements. Brex’s travel and expense features include:
- Consolidated booking for flights, hotels, and car rentals
- Integrated travel policy enforcement
- Access to a vast, unbiased global travel inventory
- Pre-negotiated discounts
- Tools to achieve 100% travel program adoption within your organization
Georgia Bio’s commitment to empowering its members is stronger than ever. With the enhanced Brex program, you can streamline financial processes, gain real-time insights into spending, and optimize travel management, all while earning industry-leading returns on your business accounts.
Georgia Life Sciences has joined 43 state and regional life sciences organizations in signing a national Council of State Bioscience Associations (CSBA) letter calling on Congress to take immediate action on three bipartisan policy priorities that are essential to sustaining U.S. leadership in biomedical innovation and supporting patients nationwide. With Congress back in session and several critical programs at risk of expiring, the letter urges congressional leaders to advance the following provisions without delay: 1. Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program The PPRV program has been instrumental in incentivizing the development of therapies for children with rare and life-threatening conditions. Its lapse threatens to slow or halt research that families across the country are counting on. 2. Extend the SBIR/STTR Programs The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide crucial early-stage capital for emerging biotech and medtech companies—many of them in Georgia. Without reauthorization, hundreds of innovative small businesses face uncertainty, jeopardizing new therapies, diagnostics, and technologies in the pipeline, 3. Advance PBM Transparency Reforms Greater transparency and accountability within pharmacy benefit manager (PBM) practices are needed to ensure that savings reach patients and employers. Reforming PBM operations is essential to strengthening access and affordability across the healthcare system. A Unified Message from the Life Sciences Community The sign-on letter reflects broad, bipartisan alignment across the national life sciences ecosystem: researchers, entrepreneurs, investors, patient advocates, and state associations all share a common message— these programs underpin America’s global competitiveness and are vital to patients who rely on continued scientific progress. Georgia Life Sciences has shared the letter with members of Georgia’s congressional delegation and will continue engaging with policymakers to emphasize the importance of swift action.
Georgia Life Sciences is proud to stand with patient advocates, providers, and employers across the state in urging Congress to take meaningful action on pharmacy benefit manager (PBM) reform. We recently signed on to a joint letter to Georgia’s Congressional Delegation stressing the urgent need for transparency, fair practices, and policies that ensure savings flow directly to patients.
Georgia Life Sciences’ CEO, Maria Thacker Goethe shares her perspective on the value of Georgia’s research universities in this month’s issue of Georgia Trend. “Georgia research institutions have felt a very significant impact from the federal rollbacks, specifically in NIH and NSF funding. Thacker Goethe’s message about the impact of research cuts is simple: Disruption shatters the foundational trust researchers have in grant continuity….” To read the full article, click here .
